| Ticker: | FHTX |
| Current Price: | $2.07 |
| % Daily Change: | 0.98% |
| Volume (1,000s): | 534.21 |
| Average Volume (1,000s): | 245.44 |
| Market Cap (M): | $124.12 |
| 1/2/2024 Price: | $8.45 |
| Change Since Inception: | -75.50% |
Foghorn Therapeutics Inc.
500 Technology Square
Suite 700
Cambridge, MA 02139
United States
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.